Postgraduate Medicine
ISSN 0032-5481 · Taylor & Francis · United Kingdom · active 1870–2026
Metrics
“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric. Citation rates differ enormously between fields, so compare within a discipline.
Indexing & access
Access status: unknown. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
Scope
Frequently asked
Is Postgraduate Medicine a predatory journal?
Our screening does not flag Postgraduate Medicine. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in Scopus, Web of Science, PubMed, which is a positive signal.
Is Postgraduate Medicine indexed in Scopus or Web of Science?
Per our venue index, Postgraduate Medicine appears in: Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.
What is Postgraduate Medicine's impact?
Papers in Postgraduate Medicine are cited about 2.0 times each within two years of publication, and Scimago places it in Q2, with an h-index of 100. This is not a Clarivate Journal Impact Factor — we neither compute nor license that metric — and a citation rate is a property of a field as much as of a journal.
Is Postgraduate Medicine open access?
We hold no reliable open-access classification for Postgraduate Medicine. Check the journal's own site for its access model and any article processing charge.
Similar venues
- Progress in Materials ScienceQ1 · Elsevier BV
- New England Journal of MedicineQ1 · Massachusetts Medical Society
- Pharmacological ReviewsQ1 · American Society for Pharmacology and Experimental Therapeutics
- Progress in Polymer ScienceQ1 · Elsevier BV
- ScienceQ1 · American Association for the Advancement of Science
- The LancetQ1 · Elsevier BV